Astera Labs (NASDAQ:ALAB) Trading Up 1% Following Analyst Upgrade

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were up 1% during trading on Thursday after Citigroup raised their price target on the stock from $160.00 to $275.00. Citigroup currently has a buy rating on the stock. Astera Labs traded as high as $262.90 and last traded at $251.88. Approximately 6,165,220 shares traded hands during trading, an increase of 24% from the average daily volume of 4,968,458 shares. The stock had previously closed at $249.38.

Other analysts also recently issued reports about the stock. Evercore ISI boosted their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, September 2nd. Zacks Research upgraded shares of Astera Labs to a “strong-buy” rating in a research report on Tuesday, August 12th. Needham & Company LLC boosted their price target on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target on the stock. in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $152.94.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total value of $1,887,000.00. Following the sale, the general counsel directly owned 161,573 shares in the company, valued at $30,488,825.10. The trade was a 5.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Sanjay Gajendra sold 91,441 shares of the business’s stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief operating officer owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,576,713 shares of company stock worth $239,237,016. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently made changes to their positions in ALAB. Alliancebernstein L.P. raised its holdings in shares of Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after acquiring an additional 4,478,741 shares during the period. Atreides Management LP raised its holdings in shares of Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after acquiring an additional 2,815,614 shares during the period. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after acquiring an additional 2,751,747 shares during the period. FengHe Fund Management Pte. Ltd. acquired a new stake in shares of Astera Labs during the second quarter valued at approximately $106,772,000. Finally, Bank of Nova Scotia raised its holdings in shares of Astera Labs by 3,742.2% during the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company’s stock valued at $57,546,000 after acquiring an additional 939,300 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

The stock’s fifty day moving average price is $166.97 and its 200-day moving average price is $108.30. The firm has a market cap of $41.87 billion, a price-to-earnings ratio of 449.79, a price-to-earnings-growth ratio of 6.32 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. The firm’s revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.